AI assistant
Sending…
Vicore Pharma Holding — Major Shareholding Notification 2021
Mar 18, 2021
3211_iss_2021-03-18_a8417e41-5320-4ed8-ace7-e53f87e609e9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vicore Pharma Holding AB
Holder
HealthCap VII L.P.
Instrument
| Instrument | Ordinary shares |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 17/03/2021 |
| Limit for number of shares | 25 % |
| Limit for number of votes | 25 % |
| After the transaction | |
| Quantity | |
| Shares | 15,929,908 |
| Directly held voting rights | 15,929,908 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 22.19878 % |
| Directly held voting rights | 22.19878 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 22.19878 % | 15,929,908 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 22.19878 % | 15,929,908 |
| Group total holdings | ||
| Voting rights 15,929,908 |
||
| Percentage of voting rights 22.19878 |
Notes (other relevant informations according to law)
Changes due to: Allotment of shares in new share issue. Flaggningen avser minskad procentuell andel av antalet aktier och röster mot bakgrund av bolagshändelse. Flaggningen är baserad på finns 71 760 293 utestående aktier i Vicore Pharma.
Published
18/03/2021 09:47
*Source of information has chosen not to submit the data
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vicore Pharma Holding
Major Shareholding Notification
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Annual Report
2026
Mar 26
Share Issue/Capital Change
2025
Nov 28
Share Issue/Capital Change
2025
Nov 28
Major Shareholding Notification
2025
Nov 27
Major Shareholding Notification
2025
Nov 14